Dr. Kumar Discusses Genetic Abnormalities in Myeloma

Shaji K. Kumar, MD
Published: Tuesday, Nov 21, 2017



Shaji K. Kumar, MD, professor of medicine, Mayo Clinic, discusses genetic abnormalities in multiple myeloma.

There has been significant progress toward understanding genetic variations in patients with multiple myeloma.

Through the use of FISH testing, abnormalities such as 17p deletion are discovered. Though there are abnormalities such as translocation present at diagnosis, these may change throughout a patient’s treatment course or when they relapse, says Kumar.


Shaji K. Kumar, MD, professor of medicine, Mayo Clinic, discusses genetic abnormalities in multiple myeloma.

There has been significant progress toward understanding genetic variations in patients with multiple myeloma.

Through the use of FISH testing, abnormalities such as 17p deletion are discovered. Though there are abnormalities such as translocation present at diagnosis, these may change throughout a patient’s treatment course or when they relapse, says Kumar.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Moving Forward From the Status Quo for the Treatment of Soft Tissue Sarcoma: Key Questions & New Answers to Optimize OutcomesAug 16, 20181.5
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Publication Bottom Border
Border Publication
x